Switch to:
More From Other Websites
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Jan 12 2015
Repros Initiates Two Phase 2B Uterine Fibroid Studies Dec 29 2014
Energy Spinoffs Transocean Partners, Seventy Seven Energy Tumble Dec 29 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Dec 29 2014
Repros Initiates Two Phase 2B Uterine Fibroid Studies Dec 29 2014
Repros Updates Androxal(R) Global Regulatory Status Dec 29 2014
Court Rules Inventors Correctly Named on Androxal(R) Patents Dec 29 2014
Court Rules Inventors Correctly Named on Androxal(R) Patents Dec 29 2014
How To Profit From The Obesity Epidemic Dec 08 2014
REPROS THERAPEUTICS INC. Financials Nov 15 2014
10-Q for Repros Therapeutics, Inc. Nov 12 2014
Brean Capital Sees No Surprises In 3Q14 Report For Repros Therapeutics Nov 11 2014
Repros Soars on Positive FDA Meeting Regarding Androxa Nov 10 2014
Repros Therapeutics Inc.(R) Reports Third Quarter 2014 Financial Results Nov 10 2014
Repros Therapeutics posts 3Q loss Nov 10 2014
Repros Therapeutics posts 3Q loss Nov 10 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition Nov 10 2014
Repros Therapeutics Inc.(R) Reports Third Quarter 2014 Financial Results Nov 10 2014
Q3 2014 Repros Therapeutics Inc Earnings Release - Before Market Open Nov 10 2014
Another lackluster session for major equities Nov 07 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK